TY  - CHAP
M1  - Book, Section
TI  - Medical Management of Lung Transplant Patients
A1  - Kao, Christina
A1  - Li, Gloria
A1  - Parulekar, Amit
A2  - Sugarbaker, David J.
A2  - Bueno, Raphael
A2  - Burt, Bryan M.
A2  - Groth, Shawn S.
A2  - Loor, Gabriel
A2  - Wolf, Andrea S.
A2  - Williams, Marcia
A2  - Adams, Ann
PY  - 2020
T2  - Sugarbaker’s Adult Chest Surgery, 3e
AB  - Successful  medical  management  of  the  lung  transplant  patient  requires  manipulation  of  the  immune  system  to  prevent  graft  rejection  while  avoiding  an  increased  risk  for  infection.  This  balance  between  rejection  and  infection  is  a  key  determinant  of  the  long-term  survival  of  these  patients.  The  pharmacologic  management  of  lung  transplant  recipients  varies  by  institution,  and  the  optimal  regimen  has  not  yet  been  defined.  Currently,  a  variety  of  induction  and  maintenance  regimens  are  used.1  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/18
UR  - accesssurgery.mhmedical.com/content.aspx?aid=1170413555
ER  -